LEGALIZATION IS A LAW. EXPUNGEMENT IS A SECOND CHANCE.
JUSTICE · SOCIAL JUSTICE
Published by Langhorne P. Breedlove
MONDAY, NOVEMBER 9, 2026 · 12:45 AM ET
Tags: Cannabis · Marijuana Legalization · Expungement · Public Health · Criminal Justice · Regulation
Dear fellow American proletariat: America has been known to arrest somebody for possessing a plant, permit a business to sell a product derived from the same plant across a state line in advertising, and then ask the person with the conviction why their employment history contains a gap. If the law changes but the record does not, society has issued a second chance with one hand and retained the handcuffs with the other.
American Proletariat proposes federally authorized adult-use cannabis regulation, coordinated with state and Tribal governments, alongside meaningful record relief for specified past cannabis offenses. Legalization, expungement, medical use, public health and taxation are different legal problems; treating them as one catchy slogan is how legislatures produce five years of litigation and a very expensive website.
AP's proposed framework would establish lawful regulated adult sales subject to age limits, product testing, accurate labeling, safeguards against youth marketing, worker protection, public-health surveillance and enforceable rules for impaired driving. It would establish a separate federal process to review and clear eligible prior nonviolent cannabis records, with explicit exclusions and individualized review for offenses involving violence, coercion, trafficking in other drugs or other independently unlawful conduct. A federal law cannot simply erase every state conviction without addressing constitutional division of authority.
States and federally recognized Tribes would retain important licensing, public-health, land-use, taxation and local-government roles under a carefully drafted federal framework. Congress must resolve interstate commerce, banking, product standards, medicinal access, impaired-driving enforcement and how federal legalization interacts with more restrictive jurisdictions. Legal adult use need not mean unrestricted commercial promotion or the right to smoke anywhere.
The federal Controlled Substances Act historically classified marijuana in Schedule I. By March 2026, a Congressional Research Service analysis described a wide gap between that federal status and state systems that had already authorized forms of medical or adult-use cannabis (Source 01). The contradiction did not vanish when state regulators issued licenses; state permission alone could not repeal federal criminal law.
On April 28, 2026, a federal final rule placed FDA-approved marijuana products and marijuana products subject to qualifying state medical-marijuana licenses into Schedule III. But marijuana outside those specified medical or approved-product categories generally remained Schedule I, and federal regulation continued to apply (Sources 02, 03). Thus, AP is proposing an additional change to federal adult-use law, not announcing that Congress has already legalized recreational cannabis.
Federal clemency also provides a lesson in precision. President Joe Biden issued proclamations in October 2022 and December 2023 addressing specified federal and District of Columbia simple-marijuana offenses. The Justice Department explains that a pardon does not expunge or erase a conviction from the record (Source 04). Forgiveness and record clearing are not interchangeable. Applicants for jobs and housing can be affected by that difference long after the press conference ends.
A Congressional Research Service report published March 10, 2026, cited survey estimates that 64.2 million U.S. residents aged 12 or older used marijuana during 2024, including 44.3 million who reported using it in the previous month (Source 01). Those are survey-based population estimates, not sales records or an endorsement of use. They show the scale of the activity regulation must confront rather than wish away.
The Centers for Disease Control and Prevention cautions that cannabis affects attention, memory, decision-making and coordination. Its research summaries identify heightened concerns with adolescent exposure and frequent use; its cannabis-use-disorder page estimates that approximately three in ten people who use cannabis have cannabis use disorder (Sources 05, 06). That estimate depends on research definitions and populations. Public-health risks do not vanish because a product becomes legal, nor does criminal punishment automatically eliminate those risks.
Driving requires particular care. The CDC reports that cannabis can impair reaction time, coordination and judgment and notes that detecting THC does not, by itself, establish the degree of impairment in an individual driver (Source 07). Enforcement should protect road safety without pretending every laboratory result proves the same thing.
Legal markets can yield public revenue, but they are not a limitless fiscal fountain. Colorado's Department of Revenue reported $236,449,405 in marijuana tax and fee revenue for calendar year 2025, while its state fiscal analysis described the different tax streams and their statutory uses (Source 08). Colorado's figures are state-specific experience, not a national federal revenue forecast. Tax rates, licensing costs, illicit competition, product prices and consumption all matter.
Congress would need to decide whether to remove adult-use cannabis from federal prohibition, establish a new federal regulatory structure, or use a different legislative design. It must specify the relationship among the Controlled Substances Act, food-and-drug rules, taxation, interstate shipment, research, banking and state or Tribal licensing. The April 2026 medical rescheduling rule supplies a current legal baseline but not an adult-use authorization (Sources 02, 03).
For expungement, legislation should define eligible federal offenses, identify a federal court or authorized administrative review process, establish access and confidentiality rules, and specify when records may still be used for carefully delimited purposes. State convictions require state legal remedies, cooperation or incentives consistent with federalism. Relief should include accessible notice and review rather than assume an eligible individual can afford counsel or decipher a docket from 1998. A presidential pardon alone does not accomplish expungement (Source 04).
Create an interagency framework for adult product classes, age verification, labeling, contamination screening, potency disclosure, packaging, recall authority, advertising limitations, environmental impacts and worker protections. Establish transparent licensing standards that allow small operators and cooperatives to participate without surrendering public-health safeguards. Examine Tribal commercial sovereignty and state implementation options in direct government-to-government consultation.
Identify eligible federal case categories and records across courts and agencies; provide an accessible automated review where lawfully feasible, notification, human appeal and free assistance. Build clear rules for sealing, expungement, vacatur or other relief; those remedies are not legally identical. Distinguish simple possession from broader offenses and provide individualized examination where the underlying record contains additional allegations. Partner with states that choose complementary relief programs without promising federal erasure of state dockets.
Fund evidence-based youth prevention, voluntary treatment for cannabis use disorder, poison-control surveillance, injury reporting, maternal-health education and independent product testing. Require honest communication about impairment and high-potency products. Establish driver-safety enforcement standards informed by impairment science, including training and evaluation instead of reliance on a single biological threshold unsupported by evidence (Sources 05, 06, 07).
Audit licensure concentration, prices, illicit-market displacement, tax compliance, youth access, workplace protections, impaired driving, enforcement disparities, record-relief completion, health outcomes and local community impacts. Review advertising restrictions and penalties for constitutionality and proportionality. Publish the data, including inconvenient results; a successful public program must survive contact with reality.
A real budget must keep separate four categories: regulatory administration, record-clearing and court costs, public-health services, and potential excise or other tax receipts. Current federal and state activity forms part of the baseline; state receipts cannot be booked as new federal revenue. The year-one model must include statute development, agency recruitment, licensing systems, testing laboratories, data security, case review, technical assistance and public communications. The ten-year model must also include enforcement, treatment, evaluation, inflation, changing market shares and uncertainties.
Illustrative arithmetic only: assume a federal program spends $100 million in its first year on administration, testing and expungement systems plus $50 million on health and legal-assistance grants. That is $150 million in first-year gross outlays. If years two through ten each require an assumed $90 million in combined ongoing spending, the flat undiscounted ten-year total is $960 million. These are scenario inputs invented to show method—not a federal cost estimate, a requested appropriation or a funded AP commitment.
If a hypothetical federal excise tax yielded $200 million annually beginning in year three, an unchanged eight-year receipt total would be $1.6 billion before tax administration, behavioral responses, avoidance, overlapping state taxes, or changes to the market. This is not a revenue projection: no national taxable base or tax rate has been established. Colorado's actual 2025 collections illustrate a state market, not the U.S. Treasury's future receipts (Source 08). Never declare net program financing by subtracting unrelated estimates or counting state and federal dollars as interchangeable.
Poorly regulated cannabis markets can encourage heavy consumption and high-potency products, expose younger people to marketing, increase intoxication-related risks and consolidate licenses among a few powerful firms. Very high taxes can leave an illicit market competitive; very low taxes may underfund oversight. Medical access, research and adult-use commerce may require distinct rules. An expungement process can fail people through bad data matching, inaccessible procedures or incomplete notice.
Critics reasonably raise adolescent mental-health risks, impaired driving, dependency, workplace safety and federal-state conflicts. Supporters of legalization point to criminal-justice costs, product oversight and the feasibility of regulating an existing market. These arguments involve both empirical questions and value judgments. AP's policy should publish measurable safeguards and revision triggers rather than treat either legalization or prohibition as a substitute for public-health evidence (Sources 05, 06, 07).
Track eligible convictions reviewed and cleared, average completion time, appeal outcomes, employment and housing barriers reported after relief, demographic disparities in enforcement, cannabis-use-disorder treatment access, emergency visits, youth initiation, impaired-driving incidents, market concentration, laboratory failures, tax receipts net of administration and law-enforcement workloads. Compare across jurisdictions and time while separating correlation from demonstrated causation.
A mature republic can argue over cannabis policy without pretending a plant is harmless or that a criminal record should be a permanent civic sentence for conduct later made lawful. If lawmakers are going to change the rules, they ought to have the courage to explain the new ones—and the competence to clean up the old ones.
01 · Congressional Research Service — The Federal Status of Marijuana and the Policy Gap with States, updated March 10, 2026.
02 · U.S. Department of Justice — Justice Department Places FDA-Approved and Qualifying State Medical Marijuana Products in Schedule III, April 23, 2026.
03 · Federal Register / Government Publishing Office — Schedules of Controlled Substances: Rescheduling of Certain Medical Marijuana Products, 91 FR 22714, April 28, 2026.
https://www.govinfo.gov/content/pkg/FR-2026-04-28/html/2026-08176.htm
04 · U.S. Department of Justice, Office of the Pardon Attorney — Frequently Asked Questions: Expungement versus Presidential Pardon.
https://www.justice.gov/pardon/frequently-asked-questions
05 · Centers for Disease Control and Prevention — Cannabis and Teens, February 15, 2024.
https://www.cdc.gov/cannabis/health-effects/cannabis-and-teens.html
06 · Centers for Disease Control and Prevention — Understanding Your Risk for Cannabis Use Disorder, December 5, 2024.
https://www.cdc.gov/cannabis/health-effects/cannabis-use-disorder.html
07 · Centers for Disease Control and Prevention — Cannabis and Driving, February 22, 2024.
https://www.cdc.gov/cannabis/health-effects/driving.html
08 · Colorado Department of Revenue — Marijuana Sales Generate Over $236M in Tax, Fee Revenue for 2025, February 19, 2026.
WE ARE ONE. · E PLURIBUS UNUM.